Claudio Tondo (Centro Cardiologico Monzio, Milan) discusses the benefits of hybrid ablation compared to the currently approved ablation methods in the treatment of atrial fibrillation. The hybrid ablation approach involves a combination of surgery with electrophysiological cathater ablation. It provides a beneficial for the treatment of patients with long-lasting and persistent atrial fibrillation. One advantage is the combining of expertise from both a surgeon and electrophysiologist within the same procedure. This gives the option to perform two ablations (endocardial and epicardial ablation) within the same surgery, which may increase the success rate in the long run. The abilty of the surgeon and electrophysiologist to review the outcome in real-time improves the efficacy and outcome of the procedure, as shown by robust data in the literature.
Patients with unsuccessful previous ablation procedures and patients with long-lasting persistent atrial fibrillation (over 1 year) are good candidates for the procedure.
Filmed at EHRA 2018, Barcelona.
View more content here.
1. What are the benefits of a hybrid ablation approach compared with other currently approved ablation methods? 0:07
2. Please describe the key efficacy and safety evidence supporting the use of hybrid ablation? 1:04
3. How do the atrial fibrillation recurrence rates compare with other approaches? 2:06
4. Are there certain patients who are more suitable for hybrid ablation? 3:05
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
Share this Video
Related Videos In Interventional Cardiology
David Keane, AF Symposium 2021: Challenges in Catheter Ablation
We spoke to Professor David Keane (St Vincent’s University Hospital, Dublin, Ireland) about the current challenges procedural duration and overall success in catheter ablation, and the most exciting innovations to aim to overcome these. Questions: What are the current challenges in catheter ablation in terms of procedural duration and overall success? (0.13) What are the […]
David Keane, AF Symposium 2021: Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
We spoke to Professor David Keane (St Vincent’s University Hospital, Dublin, Ireland) about atrial fibrillation in patients with hypertrophic cardiomyopathy. Questions: What is the incidence of atrial fibrillation (AF) in people with hypertrophic cardiomyopathy (HCM)? (0.13) What is known about the efficacy and safety of catheter ablation of AF in patients with HCM compared to […]
Andrea Natale, AF Symposium 2021: Impact of Catheter Ablation on Quality of Life and Health Care Utilization
We spoke to Dr Andrea Natale (Texas Cardiac Arrhythmia Institute, Austin, TX, USA) about the most exciting recent innovations in catheter ablation technology. Questions: What is the impact of atrial fibrillation (AF) ablation on healthcare utilization and quality of life? (0.13) How should these data influence the timing of ablation strategies? (2.40) Speaker disclosures: Dr […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!